{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:33:10Z","timestamp":1776619990587,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bbrc.2025.151358","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T07:00:51Z","timestamp":1737270051000},"page":"151358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis, molecular dynamics simulation and antimicrobial activity of novel s-triazine clubbed with three different hybrid pharmacophores"],"prefix":"10.1016","volume":"749","author":[{"given":"Riki P.","family":"Tailor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krupa G.","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Alhaji","family":"Isa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abidemi Paul","family":"Kappo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151358_bib1","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/gheg.2017.4","article-title":"Antimicrobial resistance in human populations: challenges and opportunities","volume":"2","author":"Allcock","year":"2017","journal-title":"Global Health, Epidemiol. Genomics"},{"issue":"8","key":"10.1016\/j.bbrc.2025.151358_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1473-3099(05)70189-4","article-title":"Antimicrobial resistance in developing countries. Part I: recent trends and current status","volume":"5","author":"Okeke","year":"2005","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.bbrc.2025.151358_bib3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/JCM.01983-09","article-title":"Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia","volume":"48","author":"Kariuki","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2025.151358_bib56","article-title":"The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives: an insight into molecular docking, ADMET analysis, and molecular dynamics simulation","volume":"23","author":"Yamari","year":"2023","journal-title":"Sci. African"},{"issue":"16","key":"10.1016\/j.bbrc.2025.151358_bib57","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.1080\/07391102.2022.2124456","article-title":"A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations","volume":"41","author":"Daoui","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.bbrc.2025.151358_bib55","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling: where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151358_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00044-012-0041-y","article-title":"Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction","volume":"22","author":"Patel","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"39","key":"10.1016\/j.bbrc.2025.151358_bib5","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1021\/ja026720i","article-title":"A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening","volume":"124","author":"Moon","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bbrc.2025.151358_bib6","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ejmech.2009.01.016","article-title":"Synthesis and antileishmanial activity of novel 2, 4, 6-trisubstituted pyrimidines and 1, 3, 5-triazines","volume":"44","author":"Sunduru","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bbrc.2025.151358_bib7","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/AAC.42.10.2718","article-title":"Antitrypanosomal activity of a new triazine derivative, SIPI 1029, in vitro and in model infections","volume":"42","author":"Bacchi","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2025.151358_bib8","first-page":"671","article-title":"Antimicrobial evaluation of some novel isoxazoles, cyanopyridines and pyrimidinthiones","volume":"52B","author":"Solankee","year":"2013","journal-title":"Indian J. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151358_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1211\/jpp.58.2.0009","article-title":"Evaluation of in\u2010vitro anti\u2010inflammatory activity of some 2\u2010alkyl\u20104, 6\u2010dimethoxy\u20101, 3, 5\u2010triazines","volume":"58","author":"Dianzani","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151358_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejmech.2010.12.003","article-title":"4-Anilinoquinoline triazines: a novel class of hybrid antimalarial agents","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2025.151358_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.arabjc.2011.09.013","article-title":"Synthetic and biological studies of pyrazolines and related heterocyclic compounds","volume":"7","author":"Yusuf","year":"2014","journal-title":"Arab. J. Chem."},{"issue":"4","key":"10.1016\/j.bbrc.2025.151358_bib12","first-page":"189","article-title":"An efficient synthesis of some new chalcone, acetyl pyrazoline and amino pyrimidine bearing 1, 3, 5-triazine nucleus as potential antimicrobial and antitubercular agent","volume":"2","author":"Solankee","year":"2016","journal-title":"Chem. Int."},{"issue":"17","key":"10.1016\/j.bbrc.2025.151358_bib13","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.bmc.2007.06.004","article-title":"A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics","volume":"15","author":"G\u00f6khan-Kelek\u00e7i","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2025.151358_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejmech.2006.09.006","article-title":"Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives","volume":"42","author":"\u00d6zdemir","year":"2007","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151358_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbdv.200490173","article-title":"Pyrimidine as constituent of natural biologically active compounds","volume":"2","author":"Lagoja","year":"2005","journal-title":"Chem. Biodivers."},{"issue":"14","key":"10.1016\/j.bbrc.2025.151358_bib18","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.bmcl.2014.05.002","article-title":"Studies on molecular properties prediction, antitubercular and antimicrobial activities of novel quinoline based pyrimidine motifs","volume":"24","author":"Desai","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrc.2025.151358_bib19","first-page":"13","article-title":"An efficient synthesis and antimicrobial evaluation of some new pyrazoline, pyrimidine and benzodiazepine derivatives bearing 1, 3, 5-triazine core. International Letters of Chemistry","volume":"57","author":"Solankee","year":"2015","journal-title":"Phys. Astronomy"},{"issue":"3","key":"10.1016\/j.bbrc.2025.151358_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jsps.2012.09.002","article-title":"Synthesis and anticancer activity of some fused pyrimidines and related heterocycles","volume":"21","author":"Al-Issa","year":"2013","journal-title":"Saudi Pharmaceut. J."},{"issue":"11","key":"10.1016\/j.bbrc.2025.151358_bib25","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.290.11.1500","article-title":"Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme","volume":"290","author":"Markowitz","year":"2003","journal-title":"JAMA"},{"issue":"3\u20134","key":"10.1016\/j.bbrc.2025.151358_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/dta.1843","article-title":"Investigation of the composition of anabolic tablets using near infrared spectroscopy and Raman chemical imaging","volume":"8","author":"Rebiere","year":"2016","journal-title":"Drug Test. Anal."},{"issue":"9","key":"10.1016\/j.bbrc.2025.151358_bib30","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1007\/s00044-016-1605-z","article-title":"Synthesis, spectroscopic characterization, X-ray structure, and in vivo neurotropic activity of new 1, 5-benzodiazepin-2-ones","volume":"25","author":"Gaponov","year":"2016","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151358_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/cc0501458","article-title":"Solid-phase synthesis of a library of pyrrolo [2, 1-c][1, 4] benzodiazepine-5, 11-diones with potential antitubercular activity","volume":"9","author":"Kamal","year":"2007","journal-title":"J. Combin. Chem."},{"issue":"16","key":"10.1016\/j.bbrc.2025.151358_bib26","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1016\/j.bmcl.2014.06.041","article-title":"Discovery of novel 1, 5-benzodiazepine-2, 4-dione derivatives as potential anticancer agents","volume":"24","author":"Chen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"19","key":"10.1016\/j.bbrc.2025.151358_bib31","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C5OB00655D","article-title":"1, 5-Benzodiazepine derivatives as potential antimicrobial agents: design, synthesis, biological evaluation, and structure\u2013activity relationships","volume":"13","author":"Wang","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151358_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/C3NJ01149F","article-title":"Efficient iodine-catalyzed one pot synthesis of highly functionalised pyrazoles in water","volume":"38","author":"Srivastava","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.bbrc.2025.151358_bib33","first-page":"1277","article-title":"In vitro antimycobacterial and antimicrobial activity of some new pyrazoline, isoxazole and benzodiazepine derivatives containing 1, 3, 5-triazine nucleus via chalcone series","volume":"55B","author":"Solankee","year":"2016","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.bbrc.2025.151358_bib34","article-title":"A facile synthesis and studies of some new chalcones and their derivatives based on heterocyclic ring","volume":"9","author":"Solankee","year":"2012","journal-title":"E-Journal Chem."},{"key":"10.1016\/j.bbrc.2025.151358_bib35","first-page":"109","article-title":"Synthesis, characterisation and biological screening of s-triazine based chalcones and its derivatization into phenyl pyrazolines, isoxazoles. International Letters of Chemistry","volume":"47","author":"Solankee","year":"2015","journal-title":"Phys. Astronomy"},{"key":"10.1016\/j.bbrc.2025.151358_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.126404","article-title":"Solvents and their influence on electronic properties in IEFPCM solvation model, anticancer activity, and docking studies on (E)-2-((4-chlorobenzylidene) amino) phenol","volume":"415","author":"Lisha","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bbrc.2025.151358_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140468","article-title":"Synthesis, spectroscopy, solvation effect, topology and molecular docking studies on 2, 2\u2032-((1, 2 phenylenebis (azaneylylidene)) bis (methaneylylidene)) bis (4-bromophenol)","volume":"1322","author":"Elangovan","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151358_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139346","article-title":"Synthesis, computational, reactivity analysis, non-covalent interaction and docking studies on (N1E, N2E)-N1, N2-bis (2, 4-dichlorobenzylidene)-4-methylbenzene-1, 2-diamine","volume":"1318","author":"Elangovan","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151358_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125150","article-title":"Solute-solvent interaction and adsorption studies of sulpha drug derivative: a DFT study","author":"Elangovan","year":"2024","journal-title":"J. Mol. Liq."},{"issue":"9","key":"10.1016\/j.bbrc.2025.151358_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29566","article-title":"Spectroscopic characterization, DFT, antimicrobial activity and molecular docking studies on 4, 5-bis [(E)-2-phenylethenyl]-1H, 1\u2032 H-2, 2\u2032-biimidazole","volume":"10","author":"Kiruthika","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.bbrc.2025.151358_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Modell."},{"issue":"W1","key":"10.1016\/j.bbrc.2025.151358_bib37","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.151358_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1\u20133","key":"10.1016\/j.bbrc.2025.151358_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.bbrc.2025.151358_bib40","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151358_bib41","first-page":"1","article-title":"In silico molecular docking and molecular dynamic simulation of potential inhibitors of 3C-like main proteinase (3CLpro) from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) using selected African medicinal plants","author":"Isa","year":"2020","journal-title":"Adv. Tradit. Med."},{"key":"10.1016\/j.bbrc.2025.151358_bib63","series-title":"MarvinSketch and MarvinView: Molecule Applets for the World Wide Web","author":"Csizmadia","year":"1999"},{"issue":"2","key":"10.1016\/j.bbrc.2025.151358_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1432-1033.1977.tb11885.x","article-title":"The Protein Data Bank: a computer-based archival file for macromolecular structures","volume":"80","author":"Bernstein","year":"1977","journal-title":"Eur. J. Biochem."},{"issue":"13","key":"10.1016\/j.bbrc.2025.151358_bib43","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151358_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/prot.22879","article-title":"Automated minimization of steric clashes in protein structures","volume":"79","author":"Ramachandran","year":"2011","journal-title":"Proteins"},{"issue":"14","key":"10.1016\/j.bbrc.2025.151358_bib45","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"issue":"20","key":"10.1016\/j.bbrc.2025.151358_bib64","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.1080\/07391102.2021.1936179","article-title":"Identification of potential inhibitors for LLM of Staphylococcus aureus: structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies","volume":"40","author":"Kumari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.bbrc.2025.151358_bib46","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Modell."},{"key":"10.1016\/j.bbrc.2025.151358_bib47","series-title":"Amber 2023","author":"Case","year":"2023"},{"key":"10.1016\/j.bbrc.2025.151358_bib48","first-page":"2570","article-title":"Pyrazoline heterocyclic: a review","volume":"12","author":"Dash","year":"2021","journal-title":"Int. J. Pharmaceut. Sci. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.151358_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1039\/C8MD00457A","article-title":"Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2\/pro-inflammatory cytokine inhibition","volume":"10","author":"Chandel","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.bbrc.2025.151358_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnins.2016.00265","article-title":"Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies","volume":"10","author":"Nikolic","year":"2016","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.bbrc.2025.151358_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1751-7915.2008.00070.x","article-title":"The role of the cell wall in fungal pathogenesis","volume":"2","author":"Arana","year":"2009","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.151358_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10930-020-09953-6","article-title":"Structure-based identification of potential drugs against FmtA of Staphylococcus aureus: virtual screening, molecular dynamics, MM-GBSA, and QM\/MM","volume":"40","author":"Dalal","year":"2021","journal-title":"Protein J."},{"key":"10.1016\/j.bbrc.2025.151358_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132476","article-title":"Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus","volume":"1255","author":"Kumari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2025.151358_bib52","series-title":"Therapeutic Applications of Quadruplex Nucleic Acids","author":"Neidle","year":"2011"},{"issue":"4","key":"10.1016\/j.bbrc.2025.151358_bib53","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1039\/D1CS00838B","article-title":"C\u2013H\u22ef S hydrogen bonding interactions","volume":"51","author":"Fargher","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.bbrc.2025.151358_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012029","article-title":"Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing","volume":"5","author":"Patil","year":"2010","journal-title":"PLoS One"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:11:18Z","timestamp":1740381078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":59,"alternative-id":["S0006291X25000725"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151358","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, molecular dynamics simulation and antimicrobial activity of novel s-triazine clubbed with three different hybrid pharmacophores","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151358"}}